Psyence Biomed Provides Update on Previously Announced Acquisition of Clairvoyant

2024-10-08T08:37:35+02:00October 7, 2024|Investor Information, Press Releases, Psychedelic News|

An update on previously announced proposed acquisition of Clairvoyant Therapeutics, Inc. Following the completion of necessary due diligence and other pre-closing activities specified in the conditional binding term sheet that was announced on September 9, 2024, Psyence Biomed has decided not to proceed with the acquisition at this time.